mogamulizumab kpkc - Generic Medications

Browse 1 brand name versions of mogamulizumab kpkc. Review brand names, dosage forms, strengths, and linked product records.

POTELIGEO MOGAMULIZUMAB KPKC
KYOWA KIRIN, INC. FDA Rx Only

Mogamulizumab-kpkc is a recombinant humanized monoclonal antibody that targets CC chemokine receptor 4 (CCR4)-expressing cells. Mogamulizumab-kpkc is an IgG1 kappa immunoglobulin that has a calculated molecular mass of approximately 149 kDa. Mogamulizumab-kpkc is produced by recombinant DNA technology in Chinese hamster ovary cells. POTELIGEO (mogamulizumab-kpkc) injection is a sterile, ready-to-use, preservative-free, clear to slightly opalescent colorless solution in a single-dose vial for dilution prior to intravenous infusion. Each vial contains 20 mg of mogamulizumab-kpkc in 5 mL of solution. Each mL of solution contains 4 mg of mogamulizumab-kpkc and is formulated in: citric acid monohydrate (0.44 mg), glycine (22.5 mg), polysorbate 80 (0.2 mg), and Water for Injection, USP. May contain hydrochloric acid/sodium hydroxide to adjust pH to 5.5.

About mogamulizumab kpkc Generic Drugs

This collection groups medications in our database under the generic name mogamulizumab kpkc. It currently includes 1 matching listing.

What You Can Review

Use this page to compare the set of products we have indexed for this generic name. Each result links to more detailed product information and related landing pages.

Safety Information

Always consult a qualified healthcare professional before starting, stopping, or switching any medication. The information on this page is educational and should not replace medical advice.

Medical Tools & Resources

← Back to search